Edgewise Therapeutics (EWTX) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Edgewise Therapeutics.
Bought (12 mo)
$199,403
Sold (12 mo)
$19,502,553
Insiders Buying (12 mo)
1
Insiders Selling (12 mo)
6
Form 4 Filings (All Time)
134
Most Recent Purchase
November 13, 2025
Jonathan C Fox
Director
$199,403
Most Recent Sale
August 14, 2026
Joanne M. Donovan
Officer
$412,703
Buys (90d)
0
Sells (90d)
5
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-10-02 | Fox Jonathan C | Director | Award | — | +1.2% |
| 2026-08-17 | Nofi Michael | CFO | Award | — | — |
| 2026-08-17 | Derakhshan Behrad | Officer | Award | — | — |
| 2026-08-17 | Moore John R | Officer | Award | — | — |
| 2026-08-17 | Russell Alan J | Officer | Award | — | — |
| 2026-08-17 | Donovan Joanne M. | Officer | Award | — | — |
| 2026-08-14 | Donovan Joanne M. | Officer | Sell | $412,703 | +22.9% |
| 2026-08-14 | Nofi Michael | CFO | Award | — | — |
| 2026-08-14 | Russell Alan J | Officer | Sell | $258,042 | +22.7% |
| 2026-08-14 | Koch Kevin | CEO | Sell | $785,042 | +45.0% |
| 2026-08-14 | Derakhshan Behrad | Officer | Sell | $223,424 | +28.5% |
| 2026-08-14 | Moore John R | Officer | Sell | $219,823 | +49.1% |
Sign up free to view more insider trades.